Interviews
Vestex - First clinical development program for an antimicrobial textile
29 Sep '10
2 min read
Vestex uses exclusively licensed and patented Swiss technology to repel blood and bodily fluids, wick away perspiration and control odor. The innovative, nanotechnology-based textile helps prevent contamination of the fabric while keeping the wearer clean, cool and dry.
Research at Washington Hospital Center found that Vestex-treated uniforms harbored fewer microbes than traditional scrubs, based on a study in emergency rooms and ICUs. The research was presented in a poster session at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in September.
Vestagen also completed a 16-week blind cross-over clinical trial involving Vestex technology-based products at Virginia Commonwealth University (VCU) in July. The trial compared levels of bacterial contamination, on Vestex treated scrubs versus standard scrubs. The results from study showed Vestex scrubs had significantly fewer MRSA colonies.
The evidence-based research documented during the testing proves the operational and financial benefits of Vestex as a barrier to infections. Vestex benefits have been confirmed by real doctors and nurses in major teaching hospitals, critical care units, emergency departments, trauma centers, and operating rooms.
As you are aware, this is a critical issue in the health care industry. Mounting data suggests that health care worker uniforms can harbor high levels of microorganisms. According to the Centers for Disease Control, approximately 50 percent of the nation's health care workers are exposed to contaminated fluids each day. Furthermore, the CDC estimates that every year, nearly two million patients acquire an infection in a hospital.
Ben Favret, president and CEO of Vestagen, is available to talk about the research, high-tech textiles and his business model. I can also put you in touch with the study investigators for more detail and background on antimicrobial textiles.
Research at Washington Hospital Center found that Vestex-treated uniforms harbored fewer microbes than traditional scrubs, based on a study in emergency rooms and ICUs. The research was presented in a poster session at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in September.
Vestagen also completed a 16-week blind cross-over clinical trial involving Vestex technology-based products at Virginia Commonwealth University (VCU) in July. The trial compared levels of bacterial contamination, on Vestex treated scrubs versus standard scrubs. The results from study showed Vestex scrubs had significantly fewer MRSA colonies.
The evidence-based research documented during the testing proves the operational and financial benefits of Vestex as a barrier to infections. Vestex benefits have been confirmed by real doctors and nurses in major teaching hospitals, critical care units, emergency departments, trauma centers, and operating rooms.
As you are aware, this is a critical issue in the health care industry. Mounting data suggests that health care worker uniforms can harbor high levels of microorganisms. According to the Centers for Disease Control, approximately 50 percent of the nation's health care workers are exposed to contaminated fluids each day. Furthermore, the CDC estimates that every year, nearly two million patients acquire an infection in a hospital.
Ben Favret, president and CEO of Vestagen, is available to talk about the research, high-tech textiles and his business model. I can also put you in touch with the study investigators for more detail and background on antimicrobial textiles.
Vestex
Popular News
Leave your Comments
Esteemed Clients
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Telangana State Industrial Infrastructure Corporation Limited (TSllC Ltd)")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Taiwan Textile Federation (TTF)")
